EUVIMEDEUVIMED entdecken
Crossref

RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia

Daniel Gaudet, Peter Clifton, David Sullivan, John Baker, Christian Schwabe, Susan Thackwray, Russell Scott, James Hamilton, Bruce Given, Stacey Melquist, Rong Zhou, Ting Chang und 6 weitere

NEJM Evidence · 28.11.2023 · 2 (12)

DOI: 10.1056/evidoa2200325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NEJM Evidence, erschienen am 28.11.2023. Verfasst von Daniel Gaudet und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Université de Montréal and ECOGENE 21 Clinical Research Center, Chicoutimi, Quebec, QC, Canada. Hauptthemen laut MEDLINE: Hypertriglyceridemia. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertriglyceridemiaHumansApolipoprotein C-IIIRNA Interference

Substanzen

Apolipoprotein C-III

Autor:innen und Institutionen

  • Department of Medicine, Université de Montréal and ECOGENE 21 Clinical Research Center, Chicoutimi, Quebec, QC, Canada.
  • Royal Adelaide Hospital, Adelaide, SA, Australia.
  • NSW Health Pathology, Royal Prince Alfred Hospital, Sydney.
  • Middlemore Hospital, Auckland, New Zealand.
  • Auckland Clinical Studies, Auckland, New Zealand.
  • University of the Sunshine Coast, Sippy Downs, QLD, Australia.

Zitieren

APA

Gaudet, D., Clifton, P., Sullivan, D., Baker, J., Schwabe, C., Thackwray, S., Scott, R., Hamilton, J., Given, B., Melquist, S., Zhou, R., Chang, T., San Martin, J., Watts, G. F., Goldberg, I. J., Knowles, J. W., Hegele, R. A., & Ballantyne, C. M. (2023). RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia. NEJM Evidence, 2(12). https://doi.org/10.1056/evidoa2200325

Vancouver

Gaudet D, Clifton P, Sullivan D, Baker J, Schwabe C, Thackwray S, et al. RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia. NEJM Evidence. 2023;2(12). doi:10.1056/evidoa2200325

BibTeX
@article{Gaudet2023,
  author = {Gaudet, Daniel and Clifton, Peter and Sullivan, David and Baker, John and Schwabe, Christian and Thackwray, Susan and Scott, Russell and Hamilton, James and Given, Bruce and Melquist, Stacey and Zhou, Rong and Chang, Ting and San Martin, Javier and Watts, Gerald F and Goldberg, Ira J and Knowles, Joshua W and Hegele, Robert A and Ballantyne, Christie M},
  title = {RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia},
  journal = {NEJM Evidence},
  year = {2023},
  volume = {2},
  number = {12},
  doi = {10.1056/evidoa2200325}
}
Kostenlos starten →